Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors.

Damaj MI, Carroll FI, Eaton JB, Navarro HA, Blough BE, Mirza S, Lukas RJ, Martin BR.

Mol Pharmacol. 2004 Sep;66(3):675-82.

3.

Reboxetine: functional inhibition of monoamine transporters and nicotinic acetylcholine receptors.

Miller DK, Wong EH, Chesnut MD, Dwoskin LP.

J Pharmacol Exp Ther. 2002 Aug;302(2):687-95.

4.

Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in mice.

Damaj MI, Grabus SD, Navarro HA, Vann RE, Warner JA, King LS, Wiley JL, Blough BE, Lukas RJ, Carroll FI.

J Pharmacol Exp Ther. 2010 Sep 1;334(3):1087-95. doi: 10.1124/jpet.110.166850. Epub 2010 Jun 24.

5.

A major metabolite of bupropion reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets.

Hansard MJ, Jackson MJ, Smith LA, Rose S, Jenner P.

Behav Pharmacol. 2011 Jun;22(3):269-74. doi: 10.1097/FBP.0b013e328345ca37.

PMID:
21522056
6.

Behavioral and biochemical investigations of bupropion metabolites.

Bondarev ML, Bondareva TS, Young R, Glennon RA.

Eur J Pharmacol. 2003 Aug 1;474(1):85-93.

PMID:
12909199
7.

Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.

Lukas RJ, Muresan AZ, Damaj MI, Blough BE, Huang X, Navarro HA, Mascarella SW, Eaton JB, Marxer-Miller SK, Carroll FI.

J Med Chem. 2010 Jun 24;53(12):4731-48. doi: 10.1021/jm1003232.

8.

Bupropion and bupropion analogs as treatments for CNS disorders.

Carroll FI, Blough BE, Mascarella SW, Navarro HA, Lukas RJ, Damaj MI.

Adv Pharmacol. 2014;69:177-216. doi: 10.1016/B978-0-12-420118-7.00005-6. Review.

PMID:
24484978
9.

How does bupropion work as a smoking cessation aid?

Warner C, Shoaib M.

Addict Biol. 2005 Sep;10(3):219-31. Review.

PMID:
16109583
11.

SAR studies of piperidine-based analogues of cocaine. 4. Effect of N-modification and ester replacement.

Petukhov PA, Zhang J, Kozikowski AP, Wang CZ, Ye YP, Johnson KM, Tella SR.

J Med Chem. 2002 Jul 18;45(15):3161-70.

PMID:
12109901
12.

Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.

Dhir A, Kulkarni SK.

Eur J Pharmacol. 2007 Jul 30;568(1-3):177-85. Epub 2007 May 4.

PMID:
17509558
13.

Role of dopamine in behavioral sensitization to ethanol in DBA/2J mice.

Broadbent J, Kampmueller KM, Koonse SA.

Alcohol. 2005 Feb;35(2):137-48.

PMID:
15963427
14.

Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.

Carroll FI, Runyon SP, Abraham P, Navarro H, Kuhar MJ, Pollard GT, Howard JL.

J Med Chem. 2004 Dec 2;47(25):6401-9.

PMID:
15566309
15.

Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.

Carroll FI, Muresan AZ, Blough BE, Navarro HA, Mascarella SW, Eaton JB, Huang X, Damaj MI, Lukas RJ.

J Med Chem. 2011 Mar 10;54(5):1441-8. doi: 10.1021/jm1014555. Epub 2011 Feb 14.

16.

High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo.

Ghorai SK, Cook C, Davis M, Venkataraman SK, George C, Beardsley PM, Reith ME, Dutta AK.

J Med Chem. 2003 Mar 27;46(7):1220-8.

PMID:
12646032
17.

Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.

Vann RE, Rosecrans JA, James JR, Philibin SD, Robinson SE.

Brain Res. 2006 Oct 30;1117(1):18-24. Epub 2006 Sep 1.

PMID:
16949560
18.

Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.

Sidhpura N, Redfern P, Wonnacott S.

Eur J Pharmacol. 2007 Jul 12;567(1-2):102-9. Epub 2007 Apr 6.

PMID:
17477919
19.

Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs.

Damaj MI, Slemmer JE, Carroll FI, Martin BR.

J Pharmacol Exp Ther. 1999 Jun;289(3):1229-36.

Supplemental Content

Support Center